←Back to structures
LacPavin_0818_WC40_scaffold_354720_prodigal-single.1__X__X__00016
Bact-VirLacPavin_0818_WC40_scaffold_354720_prodigal-single.1__X__X__00016
Identity
- Kingdom:
- phage
Quality
86.5
mean pLDDT
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 7-66
Domain cluster:
representative
CATH (19)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 2bayE00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.73 | 60.0 | 6.12e-01 | 90.0% | 96.6% |
| 2cklB01 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.69 | 56.0 | 5.33e-01 | 90.0% | 83.1% |
| 3mhsA01 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.67 | 52.0 | 4.13e-01 | 88.3% | 40.9% |
| 3gv4A00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.67 | 50.0 | 4.32e-01 | 86.7% | 50.5% |
| 5trbA00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.66 | 51.0 | 4.95e-01 | 85.0% | 81.2% |
| 3ddtC00 | 3.30.160.60 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Classic Zinc Finger | 0.65 | 43.0 | 4.80e-01 | 83.3% | 95.5% |
| 6kbrC00 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.63 | 39.0 | 4.07e-01 | 70.0% | 67.3% |
| 4tn3A01 | 3.30.160.60 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Classic Zinc Finger | 0.63 | 41.0 | 4.68e-01 | 81.7% | 100.0% |
| 6jzaA00 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.62 | 39.0 | 3.58e-01 | 71.7% | 46.9% |
| 4r7eA00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.62 | 50.0 | 4.82e-01 | 90.0% | 82.6% |
| 5daeA00 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.62 | 42.0 | 4.34e-01 | 71.7% | 75.4% |
| 1chcA00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.61 | 49.0 | 4.75e-01 | 90.0% | 82.4% |
| 3vk6A01 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.60 | 45.0 | 4.54e-01 | 83.3% | 91.5% |
| 4gi3C00 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.59 | 39.0 | 4.07e-01 | 71.7% | 71.9% |
| 1tbrR01 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.59 | 38.0 | 4.00e-01 | 70.0% | 76.5% |
| 2yu4A00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.59 | 48.0 | 4.27e-01 | 96.7% | 74.5% |
| 2ma6A00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.56 | 47.0 | 4.71e-01 | 100.0% | 95.1% |
| 2jveA00 | 2.10.60.10 | Mainly Beta › Ribbon › CD59 › CD59 | 0.54 | 45.0 | 4.32e-01 | 98.3% | 80.3% |
| 4ntlA01 | 3.40.190.10 | Alpha Beta › 3-Layer(aba) Sandwich › D-Maltodextrin-Binding Protein; domain 2 › Periplasmic binding protein-like II | 0.53 | 43.0 | 3.38e-01 | 93.3% | 97.1% |
ECOD (49)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 1413915 | 377.1.1.27 ↗ | few secondary structure elements › Glucocorticoid receptor-like › LIM domain-like › LIM domain-like › KDM6_GATAL | 0.81 | 58.0 | 5.37e-01 | 85.0% | 60.0% |
| 4157459 | 377.1.1.12 ↗ | few secondary structure elements › Glucocorticoid receptor-like › LIM domain-like › LIM domain-like › zf-C5HC2 | 0.81 | 61.0 | 4.30e-01 | 85.0% | 28.2% |
| 3759578 | 904.1.1.1 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain › zf-B_box | 0.81 | 54.0 | 5.47e-01 | 83.3% | 70.0% |
| 3529691 | 904.1.1.0 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain | 0.78 | 55.0 | 6.19e-01 | 80.0% | 100.0% |
| 3221207 | 376.1.6.8 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › IBR domain › zf-B_box | 0.76 | 54.0 | 6.04e-01 | 80.0% | 100.0% |
| 3636676 | 376.1.1.3 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › ZZ | 0.76 | 57.0 | 5.56e-01 | 85.0% | 73.8% |
| 3229366 | 904.1.1.1 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain › zf-B_box | 0.76 | 55.0 | 5.68e-01 | 83.3% | 83.6% |
| 3408360 | 904.1.1.3 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain › ANCHR-like_BBOX | 0.76 | 53.0 | 5.82e-01 | 81.7% | 97.8% |
| 3885685 | 904.1.1.11 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain › zf-UBP | 0.76 | 53.0 | 5.90e-01 | 80.0% | 97.8% |
| 3357823 | 904.1.1.1 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain › zf-B_box | 0.75 | 55.0 | 5.59e-01 | 83.3% | 78.3% |
| 4946824 | 101.1.2.0 ↗ | alpha arrays › HTH › HTH › winged helix domain | 0.75 | 59.0 | 3.95e-01 | 85.0% | 26.8% |
| 3928530 | 904.1.1.0 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain | 0.74 | 51.0 | 5.68e-01 | 80.0% | 97.8% |
| 3594163 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.74 | 54.0 | 5.76e-01 | 85.0% | 94.0% |
| 3601028 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.73 | 60.0 | 6.03e-01 | 88.3% | 100.0% |
| 3662931 | 904.1.1.1 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain › zf-B_box | 0.73 | 52.0 | 5.53e-01 | 83.3% | 90.0% |
| 3737763 | 377.1.1.12 ↗ | few secondary structure elements › Glucocorticoid receptor-like › LIM domain-like › LIM domain-like › zf-C5HC2 | 0.73 | 52.0 | 3.86e-01 | 85.0% | 29.7% |
| 3201162 | 377.1.1.5 ↗ | few secondary structure elements › Glucocorticoid receptor-like › LIM domain-like › LIM domain-like › LIM | 0.72 | 48.0 | 4.50e-01 | 73.3% | 54.7% |
| 3405049 | 377.1.1.0 ↗ | few secondary structure elements › Glucocorticoid receptor-like › LIM domain-like › LIM domain-like | 0.72 | 55.0 | 5.77e-01 | 81.7% | 98.2% |
| 3743942 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.71 | 58.0 | 5.08e-01 | 90.0% | 65.6% |
| 3743358 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.71 | 56.0 | 5.67e-01 | 86.7% | 100.0% |
| 3367776 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.71 | 52.0 | 5.40e-01 | 88.3% | 85.5% |
| 3545298 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.70 | 45.0 | 4.54e-01 | 70.0% | 66.1% |
| 3806578 | 376.1.1.59 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-B_box | 0.70 | 47.0 | 5.20e-01 | 80.0% | 95.6% |
| 3723908 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.70 | 54.0 | 5.27e-01 | 85.0% | 76.9% |
| 4488853 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.70 | 45.0 | 5.06e-01 | 70.0% | 86.7% |
| 4022187 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.69 | 53.0 | 4.36e-01 | 86.7% | 44.3% |
| 4991688 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.69 | 54.0 | 5.66e-01 | 83.3% | 94.3% |
| 3364276 | 904.1.1.0 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain | 0.69 | 51.0 | 5.48e-01 | 80.0% | 96.0% |
| 3219660 | 376.1.1.96 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › ZZ_ADA2 | 0.68 | 52.0 | 5.58e-01 | 83.3% | 100.0% |
| 3299584 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.68 | 50.0 | 5.37e-01 | 83.3% | 96.0% |
| 3741205 | 376.1.1.5 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-UBP | 0.67 | 50.0 | 4.24e-01 | 90.0% | 46.7% |
| 3833867 | 376.1.1.1 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4 | 0.67 | 55.0 | 4.71e-01 | 90.0% | 65.3% |
| 3866027 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.67 | 43.0 | 4.69e-01 | 70.0% | 78.0% |
| 3744884 | 376.1.1.66 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_16 | 0.67 | 52.0 | 4.88e-01 | 85.0% | 86.3% |
| 3414074 | 376.1.1.1 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4 | 0.67 | 49.0 | 5.19e-01 | 78.3% | 100.0% |
| 3927096 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.67 | 54.0 | 4.96e-01 | 90.0% | 76.2% |
| 3632969 | 192.8.1.0 ↗ | alpha bundles › Long alpha-hairpin › Eukaryotic DNA topoisomerase I, dispensable insert domain › Eukaryotic DNA topoisomerase I, dispensable insert domain | 0.67 | 52.0 | 3.34e-01 | 85.0% | 20.7% |
| 3559916 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.66 | 53.0 | 3.69e-01 | 91.7% | 27.9% |
| 3361545 | 904.1.1.1 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain › zf-B_box | 0.65 | 56.0 | 4.46e-01 | 95.0% | 75.6% |
| 150276 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.65 | 42.0 | 4.11e-01 | 70.0% | 59.1% |
| 5076504 | 376.1.1.183 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › Prok-RING_1 | 0.65 | 44.0 | 4.71e-01 | 76.7% | 86.0% |
| 3854654 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.65 | 42.0 | 4.35e-01 | 70.0% | 70.9% |
| 3185361 | 376.1.1.5 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-UBP | 0.64 | 49.0 | 4.15e-01 | 86.7% | 48.6% |
| 2323878 | 3641.1.1.0 ↗ | 0.64 | 52.0 | 5.26e-01 | 90.0% | 98.3% | |
| 4028785 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.63 | 50.0 | 4.62e-01 | 90.0% | 77.5% |
| 169512 | 379.1.1.1 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_1 | 0.61 | 39.0 | 3.89e-01 | 70.0% | 62.9% |
| 3885980 | 379.1.1.3 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_2 | 0.59 | 40.0 | 4.41e-01 | 75.0% | 91.1% |
| 3403677 | 379.1.1.3 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_2 | 0.55 | 39.0 | 4.13e-01 | 75.0% | 93.9% |
| 3402767 | 379.1.1.3 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_2 | 0.55 | 37.0 | 3.58e-01 | 70.0% | 60.0% |